Jilin Province Huinan Changlong Bio-pharmacy Dividends and Buybacks
Dividend criteria checks 2/6
Jilin Province Huinan Changlong Bio-pharmacy is a dividend paying company with a current yield of 38.34%.
Key information
38.3%
Dividend yield
n/a
Buyback Yield
Total Shareholder Yield | n/a |
Future Dividend Yield | n/a |
Dividend Growth | 57.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | HK$0.570 |
Payout ratio | n/a |
Recent dividend and buyback updates
Recent updates
Here's Why Shareholders May Consider Paying Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) CEO A Little More
May 21There May Be Reason For Hope In Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) Disappointing Earnings
Apr 04With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case
Mar 26Investors Don't See Light At End Of Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Tunnel
Dec 27With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case
Jul 12It's Unlikely That Shareholders Will Increase Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Compensation By Much This Year
Jun 05How Is Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) CEO Paid Relative To Peers?
Nov 26Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 8049 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 8049's dividend payments have increased, but the company has only paid a dividend for 6 years.
Dividend Yield vs Market
Jilin Province Huinan Changlong Bio-pharmacy Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (8049) | 38.3% |
Market Bottom 25% (HK) | 3.2% |
Market Top 25% (HK) | 8.1% |
Industry Average (Pharmaceuticals) | 3.8% |
Analyst forecast (8049) (up to 3 years) | n/a |
Notable Dividend: 8049's dividend (38.34%) is higher than the bottom 25% of dividend payers in the Hong Kong market (3.24%).
High Dividend: 8049's dividend (38.34%) is in the top 25% of dividend payers in the Hong Kong market (8.08%)
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 8049's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Insufficient data to calculate 8049's cash payout ratio to determine if its dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 11:34 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jilin Province Huinan Changlong Bio-pharmacy Company Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ssu-Han Fu | Jih Sun Securities Investment Consulting Co., Ltd. |